|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
|
|---|---|---|
| Net loss for the period | ||
| Adjustments for: | ||
| Income tax (income)/expense | ||
| Depreciation and amortization expense | ||
| Impairment of intangible assets | ||
| Impairment of receivables | ||
| Reversal of impairment loss | ||
| Gain from fair value adjustments to contingent payments | ||
| Finance expenses | ||
| Finance income | ||
| Interest expenses paid on borrowings and lease liabilities | ||
| Gain on divestment of intangible assets | ||
| Change in defined benefit obligations | ||
| Share-based payment expense | ||
| Changes in working capital: | ||
| Decrease/(Increase) in inventories | ||
| Decrease/(Increase) in trade receivables | ||
| Decrease/(Increase) in other assets | ||
| (Decrease)/increase in trade payables | ||
| (Decrease)/increase in provisions | ||
| (Decrease)/increase in other payables and liabilities | ||
| Cash flow used in operating activities | ||
| Payments for property, plant and equipment | ||
| Payments for intangible assets | ||
| Payments for other financial assets | ||
| Proceeds from partial divestment of intangible assets | ||
| Proceeds from acquisition price adjustment of intangible assets | ||
| Milestone payments related to acquisition of subsidiaries | ||
| Proceeds from other financial assets | ||
| Interest received | ||
| Cash flow from (used in) investing activities | ||
| Sale of treasury shares | ||
| Equity transaction costs | ||
| Repayment of lease liabilities | ||
| Repayment of borrowings | ||
| Cash flow from financing activities | ||
| Net increase in cash and cash equivalents | ||
| Cash and cash equivalents at beginning of period | ||
| Exchange difference on cash and cash equivalents | ||
| Cash and cash equivalents at end of period |
Loading...
